2024 first quarter consolidated sales
2024/04/16 - Financial public releases
2024 first quarter consolidated sales
2024/04/16 - Financial public releases
Virbac acquired Sasaeah, a leading animal health player in Japan.
2024/04/02 - Financial public releases
On April 1, we successfully completed the acquisition of Sasaeah. This strategic acquisition brings Virbac a leadership position in the farm animal vaccines market in Japan, notably in the cattle segment, and a large portfolio of pharmaceutical products for all the major species.
Virbac to take a leading position in Japan through the acquisition of Sasaeah
2024/03/06 - Financial public releases
Virbac announces that it has signed a definitive agreement with ORIX Corporation for the acquisition of its animal health subsidiary Sasaeah for an enterprise value of approximately €280 million.
2023 fourth quarter consolidated sales
2024/01/17 - Financial public releases